verapamil has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lercanidipine 10 mg daily was prescribed as an alternative antihypertensive drug." | 1.43 | Adverse event potentially due to an interaction between ibrutinib and verapamil: a case report. ( Bilbault, P; Gourieux, B; Lambert Kuhn, E; Levêque, D; Lioure, B, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lambert Kuhn, E | 1 |
| Levêque, D | 1 |
| Lioure, B | 1 |
| Gourieux, B | 1 |
| Bilbault, P | 1 |
| Chen, Z | 1 |
| Romaguera, J | 1 |
| Wang, M | 1 |
| Fayad, L | 1 |
| Kwak, LW | 1 |
| McCarty, N | 1 |
2 other studies available for verapamil and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Adverse event potentially due to an interaction between ibrutinib and verapamil: a case report.
Topics: Adenine; Aged; Antihypertensive Agents; Antineoplastic Agents; Cytochrome P-450 CYP3A Inhibitors; Di | 2016 |
Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Synergism; Female; Humans; Lymphoma, Mantle-C | 2012 |